Journals / International Journal of Medical Biochemistry / 2019 / Cilt: 2 - Sayı: 1

The impact of magnesium on glycemic regulation

Pages
13–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Magnesium-rich foods and/or oral magnesium supplementation may be beneficial in diabetic patients with reduced serum magnesium by increasing insulin sensitivity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Magnesium is a cofactor for the phosphorylation of glucose and many other enzymatic reactions, and a deficiency can cause insulin resistance, carbohydrate intolerance, and dyslipidemia.
📊
Key Findings & Data:Methods: The results of serum level tests of glucose, magnesium, glycated hemoglobin (HbA1c), and insulin values, as well as a lipid panel, performed for 256 patients between January 2016 and December 2017 were retrospectively evaluated.
💡
Conclusion & Impact:Magnesium-rich foods and/or oral magnesium supplementation may be beneficial in diabetic patients with reduced serum magnesium by increasing insulin sensitivity.
🔬Design:Modeling & Simulation
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: Magnesium is a cofactor for the phosphorylation of glucose and many other enzymatic reactions, and a deficiency can cause insulin resistance, carbohydrate intolerance, and dyslipidemia. A low serum magnesium level can lead to the development of diabetic complications, such as retinopathy, abnormal platelet function, cardiovascular disease, or hypertension. The aim of this study was to investigate the relationship between serum magnesium level and glucose regulation. Methods: The results of serum level tests of glucose, magnesium, glycated hemoglobin (HbA1c), and insulin values, as well as a lipid panel, performed for 256 patients between January 2016 and December 2017 were retrospectively evaluated. The patients were divided into 3 groups: nondiabetic, prediabetic, and diabetic, according to the glucose and HbA1c levels specified in the 2017 American Diabetes Association criteria. Kruskal-Wallis H and Mann-Whitney U tests were used for intergroup comparisons. Results: The patients who were nondiabetic (n=137), prediabetic (n=85), and diabetic (n=34) were aged (median [range]) 40 years (24-55), 45 years (35-58), and 48 years (30-57), respectively. There were significant differences between the nondiabetic and diabetic groups, as well as the prediabetic and diabetic groups, with respect to magnesium level (p<0.001 and p<0.001, respectively). No statistically significant difference was detected between the magnesium level of the nondiabetic and prediabetic groups. The magnesium level was significantly lower in the insulin resistant group (Homeostatic Model Assessment of Insulin Resistance [HOMA-IR] ≥2.5) (p=0.020). There was a significant negative correlation between magnesium level and glucose, HbA1c, and HOMA-IR values (r=–0.244, p<0.001; r=–0.332, p<0.001; and r=–0.162, p=0.010, respectively). Conclusion: Magnesium is a cofactor of various enzymes involved in carbohydrate oxidation and plays an important role in the transport of glucose to the cell membrane. In this study, it was observed that a low level of magnesium negatively affected glucose regulation. Magnesium-rich foods and/or oral magnesium supplementation may be beneficial in diabetic patients with reduced serum magnesium by increasing insulin sensitivity.

🔖

Cite This Article

AKŞİT, M., AKSİT, M. Z., BAŞOK, B. İ. (2019). The impact of magnesium on glycemic regulation. International Journal of Medical Biochemistry, Cilt: 2 - Sayı: 1, 13–18. https://ajindex.com/articles/167210

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fawcett WJ, Haxby EJ, Male DA. Magnesium: Physiology and pharmacology. Br J Anaesth 1999;83:302–20
  2. Jahnen‑Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012;5:i3–i14
  3. Goldman J, Fisher V. Magnesium is required in addition to calcium for insulin stimulation of glucose transport. Endocrinology 1983;112:271
  4. Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed) 1984;288:1032–4
  5. Sundaram G, Ramakrishnan T, Parthasarathy H, Moses J, Lalitha T. Evaluation of micronutrient (Zinc, Magnesium, and Copper) levels in serum and glycemic status after nonsurgical periodontal therapy in type 2 diabetic patients with chronic periodontitis. Contemp Clin Dent 2017;8:26–32
  6. Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians 2015;7:75–8
  7. Cruz KJ, de Oliveira AR, Pinto DP, Morais JB, Lima Fda S, Colli C, et al. Influence of Magnesium on insulin resistance in obese women. Biol Trace Elem Res 2014;160:305–10
  8. Yadav C, Manjrekar PA, Agarwal A, Ahmad A, Hegde A, Srikantiah RM. Association of serum selenium, zinc and magnesium levels with glycaemic indices and insulin resistance in prediabetes: a cross-sectional study from South India. Biol Trace Elem Res 2017;175:65–71
  9. Corsonello A, Ientile R, Buemi M, Cucinotta D, Mauro VN, Macaione S, et al. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 2000;20:187–92
  10. Pickup JC, Chusney GD, Crook MA, Viberti GC. Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia 1994;37:639
  11. Allegra A, Corsonello A, Buemi M, D’Angelo R, di Benedetto A, Bonanzinga S, et al. Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria. J Trace Elem Med Biol 1997;11:154–7
  12. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007;2:366–73
  13. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012;16:1000–3
  14. Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases 2014;2:488–96
  15. Tosiello L. Hypomagnesemia and diabetes mellitus: a review of clinical implications. Arch Intern Med 1996;156:1143–8